Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
The Damage to Federal Medical Research Is Already Done (Wired)
https://www.wired.com/story/life-saving-research-risks-being-destroyed-by-the-federal-funding-freeze/-snip-
Even if Trump fully reverses the freeze on research funding, the damage, multiple sources say, has been done. Although for now the funding freeze is temporary, the administration has shown how it might wield the levers of government. The implication is that withdrawing funding could be done more permanently, and could be done to individual institutions, individual organizations, both private and public. This won’t just set a precedent for the large East Coast or West Coast universities, but those located in both red and blue states alike.
While always an imperfect arrangement, science in the US is largely funded by a complex system of grant applications, reviews by peers in the field (both of which have had to be halted as part of the communications pause), and the competitive distribution of NIH funds, says Gerald Keusch, emeritus professor of medicine at Boston University and former associate director of international research for the NIH. According to its website, the NIH disburses nearly $48 billion in grants per year.
When it comes to medical research, America truly is first, and if it abdicates that position, the void left behind has global ramifications. “In Canada, we have always looked to NIH as an exemplar of what we should be trying to do,” says Austin, speaking to me independently of any roles and affiliations. “Now, that’s collapsed.”
Science is, in its very nature, collaborative. Many consortiums and alliances within scientific fields cross borders and language barriers. Some labs may be able to find additional funding from alternative sources such as the European Union. But it is unlikely that a continued withdrawal of NIH funding could be plugged by overseas support. And Big Pharma, with its seemingly endless funds, is unlikely to step up either, according to sources WIRED spoke with.
-snip-
Even if Trump fully reverses the freeze on research funding, the damage, multiple sources say, has been done. Although for now the funding freeze is temporary, the administration has shown how it might wield the levers of government. The implication is that withdrawing funding could be done more permanently, and could be done to individual institutions, individual organizations, both private and public. This won’t just set a precedent for the large East Coast or West Coast universities, but those located in both red and blue states alike.
While always an imperfect arrangement, science in the US is largely funded by a complex system of grant applications, reviews by peers in the field (both of which have had to be halted as part of the communications pause), and the competitive distribution of NIH funds, says Gerald Keusch, emeritus professor of medicine at Boston University and former associate director of international research for the NIH. According to its website, the NIH disburses nearly $48 billion in grants per year.
When it comes to medical research, America truly is first, and if it abdicates that position, the void left behind has global ramifications. “In Canada, we have always looked to NIH as an exemplar of what we should be trying to do,” says Austin, speaking to me independently of any roles and affiliations. “Now, that’s collapsed.”
Science is, in its very nature, collaborative. Many consortiums and alliances within scientific fields cross borders and language barriers. Some labs may be able to find additional funding from alternative sources such as the European Union. But it is unlikely that a continued withdrawal of NIH funding could be plugged by overseas support. And Big Pharma, with its seemingly endless funds, is unlikely to step up either, according to sources WIRED spoke with.
-snip-
5 replies
= new reply since forum marked as read
= new reply since forum marked as read
